Compliance Built to Hold Under Scrutiny
Founded in 2025, PHALANX8 was built for life sciences organizations operating in high-consequence compliance environments. PHALANX8 provides executive-level regulatory and quality leadership across the full GxP ecosystem, focused on inspection readiness, enforcement response, CAPA and remediation, quality system modernization, internal and supplier audits and outsourcing oversight, data integrity and validation, and monitoring and analytics.
PHALANX8 teams include former regulators from major enforcement agencies, alongside seasoned industry operators. This combination brings a regulator’s line of sight, evidence discipline, and execution that stands up to scrutiny.
Measurable Compliance Performance
PHALANX8 is built to perform when timelines compress and stakes rise. The work prioritizes rapid stabilization, clear governance, defensible documentation, and closure that reduces repeat observations. The objective is not activity. It is operational control, inspection-credible proof, and a compliance system that scales with the business.
What Sets Us Apart
PHALANX8 combines former regulators and industry operators to translate regulatory expectations into inspection-credible execution.
01
Regulatory Vantage Point
Former agency leaders bring direct familiarity with inspection and enforcement patterns, evidence expectations, and decision triggers.
02
Evidence Discipline
Work is grounded in traceability, documentation quality, and data integrity practices that hold up in real reviews.
03
Operating Model Rigor
Governance, decision rights, escalation paths, and performance metrics are treated as core controls, not afterthoughts.
04
Execution Under Pressure
PHALANX8 works alongside attorneys and client teams to drive cross-functional closure across sites, functions, and supplier networks.
Our Philosophy
PHALANX8 treats compliance as value protection. The firm focuses on building durable capabilities, not temporary fixes: operating discipline, clear accountability, and systems that perform under scrutiny.
